Pulmonology

The specifics of the "minor deficiencies" cited by the FDA will be relayed on June 27, 2018, upon the official issuance of the CRL.

The CDC reports that of the 2 million people who get an infection from antibiotic-resistant bacteria each year, about 23,000 die.

Children with autism are nearly twice as likely to have any allergic condition than those without autism, researchers found.

Between 60-80% of pediatric asthma exacerbations are triggered by respiratory pathogens. For most children, the common cold is the culprit.

The rare condition affects 30,000-40,000 US patients annually. Rituximab becomes its first indicated biologic treatment.

A trial of 2 different vitamin D supplementation methods found that one of them is capable of reducing recurrent wheezing in preterm infants.

The fluticasone propionate nasal spray is indicated for treatment of seasonal and perennial allergic rhinitis, as well as the management of sinus pain and pressure associated with pediatric rhinitis.

This week on MDNN: Cinnamon flavoring in e-cigarettes has been found to disrupt the lungs’ anti-bacterial defense system, new hypertension guidelines have increased the condition's prevalence, and the US Congress passed a right-to-try bill.

Benralizumab has shown a greater reduction of eosinophil levels than that of mepolizumab and reslizumab, but whether or not it's a clinically significant finding is not yet told.

The single-use triple-therapy device has proven significantly more easily managed by patients in a crossover study.

Findings should prompt future investigations into care disparities at skilled-care facilities to mediate higher mortality rates observed among senior survivors of critical illness.

When inhaled, cinnamaldehyde can disrupt the lung's anti-bacterial defense system, exposing users to respiratory infection.